SWTX - SpringWorks announces pricing of upsized public offering of common stock
2023-12-05 06:04:31 ET
More on SpringWorks Therapeutics
- SpringWorks: Springing Forward On FDA Approval, Right Into Overpriced Territory
- SpringWorks Therapeutics: Surging On Ogsiveo Approval, Long-Term Outlook Remains Unclear
- SpringWorks Therapeutics: How A Likely FDA Approval Can Kickstart The Stock's Repricing Potential
- Biggest stock movers today: GitLab, Ericsson, Nokia and more
- SpringWorks to charge $29K/month for newly approved drug: report
For further details see:
SpringWorks announces pricing of upsized public offering of common stock